Month: September 2021

Denali to present results from Phase 1 healthy volunteer study of EIF2B activator DNL343 Sanofi to present Phase 2 study plans in ALS for RIPK1 inhibitor SAR443820 Denali to host analyst and investor webinar on October 6, at 4:30 p.m. Eastern TimeSOUTH SAN FRANCISCO, Calif., Sept. 29, 2021 (GLOBE NEWSWIRE) — Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases, today announced upcoming presentations at the 2021 Annual Northeast Amyotrophic Lateral Sclerosis (NEALS) Meeting being held virtually, October 6-7. Denali will present preclinical and clinical data including results from a Phase 1 healthy volunteer study of its CNS-penetrant EIF2B activator DNL343, which is currently under...

CHARLOTTE, N.C., Sept. 29, 2021 (GLOBE NEWSWIRE) — LPL Financial LLC (Nasdaq: LPLA) announced today that the team at First Legacy Wealth Management has joined LPL Financial’s broker-dealer, corporate registered investment advisor (RIA) and custodial platforms, aligned with large enterprise JFC Advisor Network. The team reported serving over $400 million in advisory, brokerage and retirement assets*. They join LPL from Avantax Investment Services, part of Blucora. With offices in San Angelo and Big Spring, Texas, First Legacy Wealth Management, with over 75 years of combined experience, is a tax-based practice that strives to provide clients with individually tailored financial advice focused on tax implications and long-term goals. Positioning themselves with CPAs, the team specializes in retirement assets, wealth growth and legacy...

85% Are More Concerned of a Ransomware Attack Than Other Cyber ThreatsEssential to Secure Against RansomwareEssential to Secure Against RansomwareImportant Aspects of Cybersecurity SolutionsImportant Aspects of Cybersecurity SolutionsSUNNYVALE, Calif., Sept. 29, 2021 (GLOBE NEWSWIRE) — John Maddison, EVP of Products and CMO at Fortinet“According to a recent FortiGuard Labs Global Threat Landscape report, ransomware grew 1070% year over year. Unsurprisingly, organizations cited the evolving threat landscape as one of the top challenges in preventing ransomware attacks. As evidenced by our ransomware survey, there is a huge opportunity for the adoption of technology solutions like segmentation, SD-WAN, ZTNA, as well as SEG and EDR, to help protect against the threat of ransomware and the methods...

NEW YORK, Sept. 29, 2021 (GLOBE NEWSWIRE) — SFLMaven Corp. (OTC PINK: SFLM), (“SFLMaven” or the “Company”), a leading provider of high-end luxury goods, is excited to announce the signing of a Letter of Intent (the “LOI”) between the Company and artist, Larry Calabrese, toward the creation of digital artwork to form the initial foundation of the Company’s new non-fungible token (“NFT”) strategy. Calabrese is a self-taught visual artist born and raised in South Florida. He began painting around 2008 as a hobby that quickly evolved into an obsession. Over the years, he has amassed an impressive collection of completed works, from physical art to digital media. His artwork covers a vast array of different styles, from colorful abstract pieces to conceptual characters and landscapes based on sci-fi themes. He...

Award for “Spray Away” Campaign seeking to drive patient and provider awareness for the novel nasal spray treatment of symptoms of Diabetic Gastroparesis SOLANA BEACH, Calif., Sept. 29, 2021 (GLOBE NEWSWIRE) — Evoke Pharma® (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, and EVERSANA™, a leading provider of global commercial services to the life sciences industry, today announced that PM360, a publication for marketing decision makers in the pharmaceutical, biotech, and medical device industries named both companies as the Sales Aid Silver Award Winner for GIMOTI® under the Trailblazer Initiative Awards during PM360’s annual awards ceremony on September 23, 2021. Received as a result of the “Spray Away Campaign” developed by Evoke Pharma and EVERSANA ENGAGE, the Sales...

Quorum to sell both Lead Generator and Autovance Desk as GM REP certified products CALGARY, Alberta, Sept. 29, 2021 (GLOBE NEWSWIRE) — Quorum Information Technologies Inc. (TSX Venture: QIS) (Quorum) is pleased to announce that its Lead Generator software has been named a certified product under the GM Retail Excellence Program (REP) by General Motors of Canada. Lead Generator is a comprehensive tool that utilizes key analytics to allow dealerships to find customers that may be in the market for their next vehicle, including customers that have a positive equity position in their trade-in vehicle. “Lead Generator helps us anticipate a customer’s needs and find customers that may be in the market for a new vehicle,” stated Glenn Smaha, General Manager of Davis Chevrolet GMC Buick in Airdrie, AB. “Additionally, like all products...

MONTREAL, Sept. 29, 2021 (GLOBE NEWSWIRE) — Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (Theratechnologies), a biopharmaceutical company focused on the development and commercialization of innovative therapies, announced today that it will report financial results for its third quarter of fiscal 2021 ended August 31, 2021 on Wednesday, October 13, 2021. A conference call will be held on October 13, 2021 at 8:30 a.m. (ET) to discuss the results and recent business updates. The call will be hosted by Paul Lévesque, President and Chief Executive Officer. Mr. Lévesque and other members of the management team will be available to answer questions from participants following prepared remarks. The conference call can be accessed by dialing 1-844-400-1697 (toll free) or 1-703-736-7400 (International). The conference call will also...

LOUISVILLE, Ky., Sept. 29, 2021 (GLOBE NEWSWIRE) — Churchill Downs Incorporated (“CDI” or “Company”) (Nasdaq: CHDN) announced today that the Company has signed a Purchase and Sale Agreement with the Chicago Bears. The Company has agreed to sell the 326-acre property in Arlington Heights, Illinois, (“the Property”) currently the home of Arlington International Racecourse, for $197.2 million. The closing of the sale of the Property is subject to the satisfaction of various closing conditions. The Company anticipates closing the sale of the Property in late 2022 / early 2023. CDI is planning to use the proceeds of the sale to purchase or invest in replacement property that qualifies as an Internal Revenue Code §1031 transaction. About Churchill Downs Incorporated Churchill Downs Incorporated is an industry-leading racing, online wagering...

Subpopulation analysis of 74 patients from ongoing Phase 3 FURI study demonstrated similar efficacy against multiple serious fungal infections JERSEY CITY, N.J., Sept. 29, 2021 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced an oral presentation of analyses of interim data from its ongoing Phase 3 FURI study showing favorable clinical activity of oral ibrexafungerp in severe hospital-based fungal infections across multiple serious fungal infections. The compilation and disease subset analyses are being presented during IDWeek, taking place virtually September 29 – October 3, 2021. “We are very pleased to share the results of these analyses to help provide greater understanding of ibrexafungerp...